Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1

Interventions

Specimen Handling 439 Magnetic Resonance Spectroscopy 341 pembrolizumab 288 Biopsy 241 Carboplatin 230 Cisplatin 193 Cyclophosphamide 185 Paclitaxel 164 Nivolumab 153 Gemcitabine 151 Bevacizumab 121 Radiotherapy 119 Dexamethasone 113 fludarabine 99 Pemetrexed 99 Fluorouracil 94 durvalumab 90 Doxorubicin 90 venetoclax 89 Docetaxel 89 Radiation 88 Oxaliplatin 88 Rituximab 87 atezolizumab 84 Leucovorin 79 Capecitabine 75 Prednisone 74 Lenalidomide 69 Etoposide 69 X-Rays 65

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × tisotumab vedotin × 30 days × Clear all

NCT06459180 2026-05-27

TroFuse-020

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡